Makiko Ono

3.7k total citations · 2 hit papers
96 papers, 2.8k citations indexed

About

Makiko Ono is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Makiko Ono has authored 96 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Oncology, 29 papers in Pulmonary and Respiratory Medicine and 21 papers in Surgery. Recurrent topics in Makiko Ono's work include Cancer Immunotherapy and Biomarkers (11 papers), Sarcoma Diagnosis and Treatment (11 papers) and Head and Neck Cancer Studies (10 papers). Makiko Ono is often cited by papers focused on Cancer Immunotherapy and Biomarkers (11 papers), Sarcoma Diagnosis and Treatment (11 papers) and Head and Neck Cancer Studies (10 papers). Makiko Ono collaborates with scholars based in Japan, United States and United Kingdom. Makiko Ono's co-authors include Kenji Tamura, Takahiro Ochiya, Yusuke Yoshioka, Nobuyoshi Kosaka, Naoomi Tominaga, Fumitaka Takeshita, Hitoshi Tsuda, Ryou-u Takahashi, Takeshi Katsuda and Masayuki Yoshida and has published in prestigious journals such as Nucleic Acids Research, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Makiko Ono

83 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Brain metastatic cancer cells release microRNA-181c-containing extracellular vesicles capable of destructing blood–brain barrier

2015 586 citations Makiko Ono, Kenji Tamura et al. profile →
Exosomes from bone marrow mesenchymal stem cells contain a microRNA that promotes dormancy in metastatic breast cancer cells

2014 582 citations Makiko Ono, Masayuki Yoshida et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Makiko Ono Japan	20	1.5k	1.3k	1.0k	452	332	96	2.8k
Lars H. Engelholm Denmark	31	1.3k 0.8×	1.2k 0.9×	1.1k 1.1×	264 0.6×	571 1.7×	79	3.4k
David J. Shields United States	23	1.7k 1.1×	634 0.5×	648 0.6×	357 0.8×	315 0.9×	44	3.2k
Lalit R. Patel United States	18	941 0.6×	660 0.5×	1.1k 1.1×	430 1.0×	451 1.4×	26	2.3k
Shogo Ehata Japan	33	1.9k 1.2×	726 0.5×	1.2k 1.2×	326 0.7×	264 0.8×	50	2.7k
Nancy Dumont United States	23	2.5k 1.6×	735 0.6×	1.9k 1.9×	433 1.0×	545 1.6×	32	3.9k
Amy Haskell United States	11	2.1k 1.4×	813 0.6×	846 0.8×	475 1.1×	268 0.8×	11	3.4k
Geertje van der Horst Netherlands	31	1.9k 1.3×	573 0.4×	1.3k 1.2×	467 1.0×	212 0.6×	46	3.3k
Cristina Colarossi Italy	26	1.1k 0.7×	461 0.3×	604 0.6×	374 0.8×	285 0.9×	80	2.3k
Brett G. Hollier Australia	23	1.4k 0.9×	754 0.6×	1.2k 1.2×	373 0.8×	176 0.5×	46	2.5k
Lisa M. Arendt United States	24	1.3k 0.8×	736 0.6×	1.8k 1.8×	245 0.5×	231 0.7×	54	2.8k

Countries citing papers authored by Makiko Ono

Since Specialization

Citations

This map shows the geographic impact of Makiko Ono's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Makiko Ono with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Makiko Ono more than expected).

Fields of papers citing papers by Makiko Ono

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Makiko Ono. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Makiko Ono. The network helps show where Makiko Ono may publish in the future.

Co-authorship network of co-authors of Makiko Ono

This figure shows the co-authorship network connecting the top 25 collaborators of Makiko Ono. A scholar is included among the top collaborators of Makiko Ono based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Makiko Ono. Makiko Ono is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ono, Makiko, et al.. (2025). Appearance-related needs and challenges among cancer patients undergoing systemic therapy: a comprehensive survey study. International Journal of Clinical Oncology. 30(3). 469–479.

Fukuda, Naoki, Kazuhisa Toda, Ryosuke Oki, et al.. (2024). Clinical impact of proteinuria on renal function and treatment outcomes in patients with radioiodine-refractory thyroid cancer treated with lenvatinib. Endocrine Journal. 71(4). 363–371. 1 indexed citations

Nishizawa, Aya, Koichi Takeda, Tetsuya Urasaki, et al.. (2023). Severe drug eruption after antibiotic administration in patients receiving immune checkpoint inhibitors: A monocentric case series. SHILAP Revista de lepidopterología. 2(2). 330–337.

Ithimakin, Suthinee, Napa Parinyanitikul, Sung‐Bae Kim, et al.. (2022). Disparities in Access to Systemic Treatment for Breast Cancer in Thailand and Major Asian Territories. Journal of Breast Cancer. 25(3). 207–207. 5 indexed citations

Hara, Fumikata, Makiko Ono, Shigehisa Kitano, et al.. (2022). 160TiP A randomized controlled phase III study of bevacizumab and paclitaxel in combination with atezolizumab as a treatment for patients with locally advanced or metastatic hormone receptor-positive HER2-negative breast cancer: JCOG1919E/AMBITION study. Annals of Oncology. 33. S193–S193. 1 indexed citations

Sato, Yasuyoshi, Kenji Nakano, Xiaofei Wang, et al.. (2021). Pre-Treatment Neutrophil-to-Lymphocyte Ratio (NLR) as a Predictive Marker of Pazopanib Treatment for Soft-Tissue Sarcoma. Cancers. 13(24). 6266–6266. 10 indexed citations

Fukuda, Naoki, Mayu Yunokawa, Yu Fujiwara, et al.. (2020). Comparison of the efficacy and safety of the EXTREME regimen for treating recurrent or metastatic head and neck squamous cell carcinoma in older and younger adult patients. Cancer Reports. 4(2). e1322–e1322. 7 indexed citations

Nakano, Kenji, Keiko Hayakawa, Yuki Funauchi, et al.. (2020). Differences in the efficacy and safety of eribulin in patients with soft tissue sarcoma by histological subtype and treatment line. Molecular and Clinical Oncology. 14(1). 13–13. 6 indexed citations

Sugano, Teppei, Masayuki Yoshida, Mari Masuda, et al.. (2020). Prognostic impact of ACTN4 gene copy number alteration in hormone receptor-positive, HER2-negative, node-negative invasive breast carcinoma. British Journal of Cancer. 122(12). 1811–1817. 7 indexed citations

10.

Tamura, Keita, Shunji Takahashi, Toru Mukohara, et al.. (2020). 346P Phase I study of the liposomal formulation of eribulin (E7389-LF): Results from the HER2-negative breast cancer expansion. Annals of Oncology. 31. S385–S385.

11.

Ono, Makiko, et al.. (2011). Physiological and psychological responses induced by expressing empathy with others. Japan Journal of Nursing Science. 9(1). 56–62. 6 indexed citations

12.

Ono, Makiko, Hitoshi Tsuda, Chikako Shimizu, et al.. (2011). Tumor-infiltrating lymphocytes are correlated with response to neoadjuvant chemotherapy in triple-negative breast cancer. Breast Cancer Research and Treatment. 132(3). 793–805. 245 indexed citations

13.

Yonemori, Kan, Koji Tsuta, Chikako Shimizu, et al.. (2010). Immunohistochemical expression of HER1, HER3, and HER4 in HER2‐positive breast cancer patients treated with trastuzumab‐containing neoadjuvant chemotherapy. Journal of Surgical Oncology. 101(3). 222–227. 17 indexed citations

14.

Hashimoto, Kenji, Kan Yonemori, Chikako Shimizu, et al.. (2010). A retrospective study of the impact of age on patterns of care for elderly patients with metastatic breast cancer. Medical Oncology. 28(2). 434–440. 3 indexed citations

15.

Ono, Makiko, Masashi Ando, Mayu Yunokawa, et al.. (2009). Brain metastases in patients who receive trastuzumab-containing chemotherapy for HER2-overexpressing metastatic breast cancer. International Journal of Clinical Oncology. 14(1). 48–52. 30 indexed citations

16.

Ono, Makiko, et al.. (2009). Physiological and Psychological Responses to Expressions of Emotion and Empathy in Post-Stress Communication. Journal of PHYSIOLOGICAL ANTHROPOLOGY. 28(1). 29–35. 12 indexed citations

17.

Ono, Makiko, Kazuhiro Hasegawa, Shigeo Tanaka, et al.. (2008). Incidence of gingival overgrowth caused by calcium channel blockers. 27(2). 79–85. 6 indexed citations

18.

Ono, Makiko, et al.. (2007). Psychological effects of tablecloth color on diners under different brightness. Journal for the Integrated Study of Dietary Habits. 18(1). 48–55. 1 indexed citations

19.

Hirai, Syu-ichi, et al.. (2005). Expression of MUK/DLK/ZPK, an activator of the JNK pathway, in the nervous systems of the developing mouse embryo. Gene Expression Patterns. 5(4). 517–523. 45 indexed citations

20.

Ono, Makiko, Shigeo Tanaka, Hitoshi Nishimura, et al.. (2004). Incidence of gingival overgrowth induced by calcium channel blocker. Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics. 35(1). 159S–159S.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact